About the Authors
- Craig E Eckfeldt
-
Contributed equally to this work with: Craig E Eckfeldt, Eric M Mendenhall
Affiliation Department of Medicine, Division of Hematology, Oncology, and Transplantation, and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America
- Eric M Mendenhall
-
Contributed equally to this work with: Craig E Eckfeldt, Eric M Mendenhall
Affiliation Department of Medicine, Division of Hematology, Oncology, and Transplantation, and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America
- Catherine M Flynn
-
Affiliation Department of Medicine, Division of Hematology, Oncology, and Transplantation, and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America
- Tzu-Fei Wang
-
Affiliation Department of Medicine, Division of Hematology, Oncology, and Transplantation, and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America
- Michael A Pickart
-
Affiliation Genetics, Cell Biology, and Development and Arnold and Mabel Beckman Center for Transposon Research, University of Minnesota, Minneapolis, Minnesota, United States of America
- Suzanne M Grindle
-
Affiliation Cancer Center Bioinformatics Division, University of Minnesota, Minneapolis, Minnesota, United States of America
- Stephen C Ekker
-
Affiliation Genetics, Cell Biology, and Development and Arnold and Mabel Beckman Center for Transposon Research, University of Minnesota, Minneapolis, Minnesota, United States of America
- Catherine M Verfaillie
-
*To whom correspondence should be addressed. E-mail: verfa001@umn.edu
Affiliation Department of Medicine, Division of Hematology, Oncology, and Transplantation, and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, United States of America
Competing Interests
University of Minnesota and Stephen C. Ekker are cofounders and shareholders of a small biotechnology company called Discovery Genomics Inc. that has the exclusive license for the commercial use of morpholinos in zebrafish. Dr. Ekker is a consultant to this company.
Author Contributions
CEE, EMM, SCE, and CMV conceived and designed the experiments. CEE, EMM, CMF, and TFW performed the experiments. CEE, EMM, CMF, TFW, SMG, SCE, and CMV analyzed the data. MAP and SMG contributed reagents/materials/analysis tools. CEE, EMM, SCE, and CMV wrote the paper.